OVERVIEW
Herpes zoster, also known as shingles, is a common viral disease with about one million cases occurring each year in the United States. In October 2017, the Food and Drug Administration (FDA) approved a 2-dose, recombinant zoster vaccine ([RZV], Shingrix), for the prevention of herpes zoster in adults aged ≥50 years. The Centers for Disease Control and Prevention (CDC) recommends Shingrix for use in immunocompetent adults age ≥50 years. During this COCA Call, clinicians will learn about CDC recommendations for herpes zoster vaccines and the clinical guidelines for the new vaccine.
The recordings (audio, slides, and transcript) for this call will be posted on the webpage a week after the COCA Call.
Free Continuing Education (CE) is available for most COCA Calls. Please see below for instructions on how to receive CE.
WEBINAR INFORMATION
Date : Thursday, May 10, 2018
Time : 2:00-3:00 P.M. ET
At the time of this webinar, please click the link below to join the webinar:
https://zoom.us/j/101402913
Or iPhone one-tap :
US: +14086380968,,101402913# or +16468769923,,101402913#
Or Telephone :
US: +1 408 638 0968 or +1 646 876 9923 or +1 669 900 6833
Webinar ID: 101 402 913
International numbers available: https://zoom.us/u/bLkRouQtj
OBJECTIVES
At the conclusion of this COCA Call, the participant will be able to accomplish the following:
- List CDC’s recommendations on herpes zoster vaccines, in particular, new guidelines for Shingrix.
- Explain who should receive Shingrix and how to administer it.
- Describe the benefits and side effects of Shingrix.
PRESENTER
Kathleen Dooling, MD, MPH
Medical Officer
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
OBTAINING CONTINUING EDUCATION (CE)
To receive continuing education (CE) for WC2922-051018 – (Live) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for the Use of Herpes Zoster Vaccines – May 10, 2018, please visit TCEO and follow these 9 Simple Steps by June 11, 2018.
To receive continuing education (CE) for WD2922-051018 – (Enduring) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for the Use of Herpes Zoster Vaccines – May 10, 2018 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by June 12, 2020.